Palisade Bio, Inc.

PALI • NASDAQ • Stock Fundamentals

Palisade Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO J. D. Finley, with a market cap of $309.3M.

Market Cap$309.3M

Employees9.0

CEOJ. D. Finley

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 1 month 2 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Palisade Bio, Inc.

Palisade Bio, Inc. (PALI) has a market capitalization of $309.3M and trades on NASDAQ.

Palisade Bio, Inc. has approximately 9 employees.